Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm, Sweden

被引:27
作者
Ramqvist, Torbjorn [1 ]
Du, Juan
Lunden, Mikaela [2 ]
Ahrlund-Richter, Sofie
Ferreira, Joana
Marions, Lena [3 ]
Sparen, Par [4 ]
Andersson, Soren [2 ]
Dalianis, Tina [2 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska R8 01, SE-17176 Stockholm, Sweden
[2] Swedish Inst Infect Dis Control, Solna, Sweden
[3] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Solna, Sweden
[4] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
PARTICLE VACCINE; YOUNG-WOMEN; HPV TYPES; SUSTAINED EFFICACY; NATURAL-HISTORY; CERVICAL-CANCER; INFECTION; POPULATION; RISK;
D O I
10.3109/00365548.2010.526957
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Knowledge of the prevalence of different human papillomavirus (HPV) types in young girls is important for the early detection of changes in HPV prevalence, e.g. due to HPV vaccines. The purpose of this study was to obtain information on the prevalence of 24 different genital HPV types in a group of sexually active young women (aged 15-23 y) attending a major youth healthcare centre in Stockholm, before the introduction of public HPV vaccination of young women in the autumn of 2010. A total of 615 women were analyzed for 24 different, mainly high-risk HPV (HR-HPV) types using multiplex polymerase chain reaction and Luminex technology. A high HPV prevalence in this cohort was demonstrated, particularly with regard to HPV16, but also to all included HR-HPV types. Of the 544 successfully analyzed samples from non-vaccinated individuals, 70% were positive for the HPV types assayed for, and 62% were positive for HR-HPV types. Over a third (34.7%) of the women were infected with HPV16, and a high frequency of infections with HR-HPV types 51 (10.7%), 18 (10.1%), 52 (9.9%) and 73 (9.4%) was also observed. At least 9 different non-vaccine HR-HPV types were present with a prevalence of >6% in this selected group of young women.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 29 条
  • [1] Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, south Italy
    Ammatuna, Pietro
    Giovannelli, Lucia
    Matranga, Domenica
    Ciriminna, Saverio
    Perino, Antonio
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (08) : 2002 - 2006
  • [2] The role of human papillomavirus in cervical adenocarcinoma carcinogenesis
    Andersson, S
    Rylander, E
    Larsson, B
    Strand, A
    Silfversvärd, C
    Wilander, E
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (02) : 246 - 250
  • [3] [Anonymous], VACCINE S3
  • [4] High prevalence of HPV among female students in Finland
    Auvinen, E
    Niemi, M
    Malm, C
    Zilliacus, R
    Trontti, A
    Fingerroos, R
    Lehtinen, M
    Paavonen, J
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2005, 37 (11-12) : 873 - 876
  • [5] The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
    Brown, Darron R.
    Kjaer, Susanne K.
    Sigurdsson, Kristjan
    Iversen, Ole-Erik
    Hernandez-Avila, Mauricio
    Wheeler, Cosette M.
    Perez, Gonzalo
    Koutsky, Laura A.
    Tay, Eng Hseon
    Garcia, Patricia
    Ault, Kevin A.
    Garland, Suzanne M.
    Leodolter, Sepp
    Olsson, Sven-Eric
    Tang, Grace W. K.
    Ferris, Daron G.
    Paavonen, Jorma
    Steben, Marc
    Bosch, F. Xavier
    Dillner, Joakim
    Joura, Elmar A.
    Kurman, Robert J.
    Majewski, Slawomir
    Munoz, Nubia
    Myers, Evan R.
    Villa, Luisa L.
    Taddeo, Frank J.
    Roberts, Christine
    Tadesse, Amha
    Bryan, Janine
    Lupinacci, Lisa C.
    Giacoletti, Katherine E. D.
    Sings, Heather L.
    James, Margaret
    Hesley, Teresa M.
    Barra, Eliav
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (07) : 926 - 935
  • [6] Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
    Coupe, V. M. H.
    Berkhof, J.
    Bulkmans, N. W. J.
    Snijders, P. J. F.
    Meijer, C. J. L. M.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (03) : 646 - 651
  • [7] Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors
    Dahlgren, L
    Mellin, H
    Wangsa, D
    Heselmeyer-Haddad, K
    Björnestål, L
    Lindholm, J
    Munck-Wkland, E
    Auer, G
    Ried, T
    Dalianis, T
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (02) : 244 - 249
  • [8] Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology:: a meta-analysis
    de Sanjose, Silvia
    Diaz, Mireia
    Castellsague, Xavier
    Clifford, Gary
    Bruni, Laia
    Munoz, Nubia
    Bosch, F. Xavier
    [J]. LANCET INFECTIOUS DISEASES, 2007, 7 (07) : 453 - 459
  • [9] Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
    Harper, DM
    Franco, EL
    Wheeler, C
    Ferris, DG
    Jenkins, D
    Schuind, A
    Zahaf, T
    Innis, B
    Naud, P
    De Carvalho, NS
    Roteli-Martins, CM
    Teixeira, J
    Blatter, MM
    Korn, AP
    Quint, W
    Dubin, G
    [J]. LANCET, 2004, 364 (9447) : 1757 - 1765
  • [10] Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
    Harper, DM
    Franco, EL
    Wheeler, CM
    Moscicki, AB
    Romonowski, B
    Roteli-Martins, CM
    Jenkins, D
    Schuind, A
    Clemens, SAC
    Dubin, G
    [J]. LANCET, 2006, 367 (9518) : 1247 - 1255